Trial Profile

Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 20 Oct 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Testosterone (Primary)
Indications Hypogonadism
Focus Adverse reactions; Therapeutic Use

Most Recent Events

21 Oct 2020 Results of a post hoc analysis assessing the predictors of changes in semen parameters in men who received Natesto, presented at the American Society for Reproductive Medicine Scientific Congress 2020
20 Aug 2020 All the primary end-points have been updated with a changed time-frame, few end-points like serum analysis, Sexual Health Inventory in Men (SHIM)- have been removed, while the others have been modified and a new safety/adverse-reaction end-point is added.
03 Jun 2020 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com